Amount of nasal spray vaccine hurts H1N1 efforts
Photo credit: Getty Images | A regulator checks the production of H1N1 vaccines by the Sanofi-Pasteur manufacturer on October 19, 2009 in Val-de-Reuil, western Paris. Sanofi-Pasteur produces almost ten million H1N1 vaccines per week, the most significant production rate in the world.
Swine flu fears on LI, NYC, around the world
The state's swine flu vaccine program has been hampered because more than a third of the doses have been in the form of nasal spray, which can't be given to high-risk groups such as pregnant women and children with underlying medical problems.
That has been "really seriously limiting," said Claire Pospisil, a state health department spokeswoman.
The state's predicament is reflected nationally:...
